Integrative multi-omics identifies high risk multiple myeloma subgroup associated with significant DNA loss and dysregulated DNA repair and cell cycle pathways

MLA

María Ortiz-Estévez, et al. “Integrative Multi-Omics Identifies High Risk Multiple Myeloma Subgroup Associated with Significant DNA Loss and Dysregulated DNA Repair and Cell Cycle Pathways.” BMC Medical Genomics, vol. 14, no. 1, Dec. 2021, pp. 1–14. EBSCOhost, https://doi.org/10.1186/s12920-021-01140-5.

APA

María Ortiz-Estévez, Fadi Towfic, Erin Flynt, Nicholas Stong, In Sock Jang, Kai Wang, Matthew W. B. Trotter, & Anjan Thakurta. (2021). Integrative multi-omics identifies high risk multiple myeloma subgroup associated with significant DNA loss and dysregulated DNA repair and cell cycle pathways. BMC Medical Genomics, 14(1), 1–14. https://doi.org/10.1186/s12920-021-01140-5

Chicago

María Ortiz-Estévez, Fadi Towfic, Erin Flynt, Nicholas Stong, In Sock Jang, Kai Wang, Matthew W. B. Trotter, and Anjan Thakurta. 2021. “Integrative Multi-Omics Identifies High Risk Multiple Myeloma Subgroup Associated with Significant DNA Loss and Dysregulated DNA Repair and Cell Cycle Pathways.” BMC Medical Genomics 14 (1): 1–14. doi:10.1186/s12920-021-01140-5.